|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Chambers AF, Groom AC and MacDonald IC:
Dissemination and growth of cancer cells in metastatic sites. Nat
Rev Cancer. 2:563–572. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Clevers H: Wnt/beta-catenin signaling in
development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
van Amerongen R, Mikels A and Nusse R:
Alternative wnt signaling is initiated by distinct receptors. Sci
Signal. 1:re92008.PubMed/NCBI
|
|
5
|
MacDonald BT, Tamai K and He X:
Wnt/beta-catenin signaling: components, mechanisms, and diseases.
Dev Cell. 17:9–26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Howe LR and Brown AM: Wnt signaling and
breast cancer. Cancer Biol Ther. 3:36–41. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
van de Wetering M, Barker N, Harkes IC, et
al: Mutant E-cadherin breast cancer cells do not display
constitutive Wnt signaling. Cancer Res. 61:278–284. 2001.PubMed/NCBI
|
|
8
|
Bafico A, Liu G, Goldin L, Harris V and
Aaronson SA: An autocrine mechanism for constitutive Wnt pathway
activation in human cancer cells. Cancer Cell. 6:497–506. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Schlange T, Matsuda Y, Lienhard S, Huber A
and Hynes NE: Autocrine WNT signaling contributes to breast cancer
cell proliferation via the canonical WNT pathway and EGFR
transactivation. Breast Cancer Res. 9:R632007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Matsuda Y, Schlange T, Oakeley EJ, Boulay
A and Hynes NE: WNT signaling enhances breast cancer cell motility
and blockade of the WNT pathway by sFRP1 suppresses MDA-MB-231
xenograft growth. Breast Cancer Res. 11:R322009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Nelson WJ and Nusse R: Convergence of Wnt,
beta-catenin, and cadherin pathways. Science. 303:1483–1487. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Yang P, An H, Liu X, Wen M, Zheng Y, Rui Y
and Cao X: The cytosolic nucleic acid sensor LRRFIP1 mediates the
production of type I interferon via a beta-catenin-dependent
pathway. Nat Immunol. 11:487–494. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu C, Li Y, Semenov M, et al: Control of
beta-catenin phosphorylation/degradation by a dual-kinase
mechanism. Cell. 108:837–847. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Ikeda S, Kishida S, Yamamoto H, Murai H,
Koyama S and Kikuchi A: Axin, a negative regulator of the Wnt
signaling pathway, forms a complex with GSK-3beta and beta-catenin
and promotes GSK-3beta-dependent phosphorylation of beta-catenin.
EMBO J. 17:1371–1384. 1998. View Article : Google Scholar
|
|
15
|
Kitagawa M, Hatakeyama S, Shirane M, et
al: An F-box protein, FWD1, mediates ubiquitin-dependent
proteolysis of beta-catenin. EMBO J. 18:2401–2410. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yost C, Torres M, Miller JR, Huang E,
Kimelman D and Moon RT: The axis-inducing activity, stability, and
subcellular distribution of beta-catenin is regulated in Xenopus
embryos by glycogen synthase kinase 3. Genes Dev. 10:1443–1454.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu C, Kato Y, Zhang Z, Do VM, Yankner BA
and He X: beta-Trcp couples beta-catenin
phosphorylation-degradation and regulates Xenopus axis formation.
Proc Natl Acad Sci USA. 96:6273–6278. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wolf D, Rodova M, Miska EA, Calvet JP and
Kouzarides T: Acetylation of beta-catenin by gapdh (CBP). J Biol
Chem. 277:25562–25567. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Levy L, Wei Y, Labalette C, Wu Y, Renard
CA, Buendia MA and Neuveut C: Acetylation of beta-catenin by p300
regulates beta-catenin-Tcf4 interaction. Mol Cell Biol.
24:3404–3414. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhu J, Coyne CB and Sarkar SN: PKC alpha
regulates Sendai virus-mediated interferon induction through HDAC6
and β-catenin. EMBO J. 30:4838–4849. 2011.PubMed/NCBI
|
|
21
|
Jho EH, Zhang T, Domon C, Joo CK, Freund
JN and Costantini F: Wnt/beta-catenin/Tcf signaling induces the
transcription of Axin2, a negative regulator of the signaling
pathway. Mol Cell Biol. 22:1172–1183. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Roose J, Huls G, van Beest M, et al:
Synergy between tumor suppressor APC and the beta-catenin-Tcf4
target Tcf1. Science. 285:1923–1926. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Li Y, Zhang X, Polakiewicz RD, Yao TP and
Comb MJ: HDAC6 is required for epidermal growth factor-induced
beta-catenin nuclear localization. J Biol Chem. 283:12686–12690.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Takahashi-Yanaga F and Sasaguri T: The
Wnt/beta-catenin signaling pathway as a target in drug discovery. J
Pharmacol Sci. 104:293–302. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Morin PJ, Sparks AB, Korinek V, Barker N,
Clevers H, Vogelstein B and Kinzler KW: Activation of
beta-catenin-Tcf signaling in colon cancer by mutations in
beta-catenin or APC. Science. 275:1787–1790. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Fraga MF, Ballestar E, Villar-Garea A, et
al: Loss of acetylation at Lys16 and trimethylation at Lys20 of
histone H4 is a common hallmark of human cancer. Nat Genet.
37:391–400. 2005. View
Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lin YY, Kiihl S, Suhail Y, et al:
Functional dissection of lysine deacetylases reveals that HDAC1 and
p300 regulate AMPK. Nature. 482:251–255. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
von Kries JP, Winbeck G, Asbrand C, et al:
Hot spots in beta-catenin for interactions with LEF-1, conductin
and APC. Nat Struct Biol. 7:800–807. 2000.PubMed/NCBI
|
